A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.
Clinical trial NCT04903093 · COMPLETED
Trial details
- NCT number
- NCT04903093
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-04
- Primary completion
- 2021-10-26
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.